Bronchodilator Drugs - Algeria

Algeria

In Algeria, the revenue in the Bronchodilator Drugs market is estimated to reach US$27.83m in 2024.
It is anticipated that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 2.81%, leading to a market volume of US$31.97m by 2029.
When compared globally, United States is expected to generate the highest revenue, amounting to US$17,340.00m in 2024.
Algeria's increasing demand for bronchodilator drugs reflects the rising prevalence of respiratory diseases in the country.

Key regions: United States, Europe, Brazil, Japan, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

Bronchodilator drugs are an essential component of the pharmaceutical industry, catering to the needs of patients with respiratory disorders. Algeria, being a developing country, has witnessed a surge in the demand for bronchodilator drugs in recent years.

Customer preferences: The Algerian market for bronchodilator drugs is primarily driven by the increasing prevalence of respiratory disorders, such as asthma and chronic obstructive pulmonary disease (COPD). The country has a high smoking rate, which further exacerbates the respiratory problems of the population. As a result, there is a growing demand for bronchodilator drugs that can provide quick relief from breathing difficulties.

Trends in the market: In recent years, the Algerian government has implemented several measures to improve the healthcare infrastructure of the country. This has led to an increase in the availability of bronchodilator drugs in the market. The trend of self-medication is prevalent in Algeria, which has led to an increase in the sales of over-the-counter (OTC) bronchodilator drugs. However, the trend is shifting towards prescription-based drugs due to the increasing awareness of the potential side effects of OTC drugs.

Local special circumstances: The Algerian market for bronchodilator drugs is highly competitive, with several domestic and international players operating in the market. The market is dominated by generic drugs, which are cheaper than their branded counterparts. The government has implemented price control measures to make the drugs affordable for the general population. However, the quality of the generic drugs is a concern for the consumers, which has led to a preference for branded drugs.

Underlying macroeconomic factors: Algeria is heavily dependent on oil and gas exports, which account for a significant portion of the country's GDP. The recent decline in oil prices has led to a decrease in government revenues, which has affected the healthcare sector. The government has reduced its healthcare expenditure, which has led to a shortage of essential drugs in the market. However, the government is taking steps to increase local production of drugs to reduce the dependence on imports. This is expected to boost the bronchodilator drugs market in the country.In conclusion, the bronchodilator drugs market in Algeria is witnessing a steady growth due to the increasing prevalence of respiratory disorders and the improving healthcare infrastructure. The trend of self-medication is shifting towards prescription-based drugs, and the market is highly competitive with a preference for branded drugs. The decline in oil prices has affected the healthcare sector, but the government's efforts to increase local production of drugs are expected to boost the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.